Bridgeway Capital Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $150K | Sell |
104,900
-25,000
| -19% | -$35.8K | ﹤0.01% | 1015 |
|
|
2025
Q1 | $208K | Buy |
+129,900
| New | +$208K | 0.01% | 920 |
|
|
2024
Q3 | – | Sell |
-49,000
| Closed | -$226K | – | 1268 |
|
|
2024
Q2 | $226K | Hold |
49,000
| – | – | 0.01% | 1030 |
|
|
2024
Q1 | $400K | Sell |
49,000
-75,000
| -60% | -$613K | 0.01% | 980 |
|
|
2023
Q4 | $701K | Sell |
124,000
-25,000
| -17% | -$141K | 0.02% | 851 |
|
|
2023
Q3 | $277K | Buy |
149,000
+49,000
| +49% | +$91.1K | 0.01% | 1028 |
|
|
2023
Q2 | $275K | Buy |
+100,000
| New | +$275K | 0.01% | 1064 |
|